Folitrax 7.5 (Methotrexate (7.5mg))

Folitrax 7.5 Tablet is indicated for the management of cancer across different regions of the body. It is also utilized in the treatment of rheumatoid arthritis, severe psoriasis that is resistant to other treatments, and Crohn’s disease. The mechanism of action involves the inhibition of the proliferation of abnormal cells and the modulation of immune activity in conditions characterized by autoimmune responses. This medication can be prescribed as a standalone treatment or in conjunction with other therapeutic agents. It is crucial to adhere strictly to your healthcare provider’s instructions regarding dosage and administration. Overdosing may result in severe adverse reactions. Patience is necessary, as it may take weeks or even months to notice therapeutic benefits; thus, discontinuation of the medication should only occur upon your doctor’s advice. Commonly reported adverse effects include mouth ulcers, alopecia, reduced blood cell counts, elevated liver enzymes, nausea, and gastrointestinal discomfort. Your healthcare professional may suggest folic acid supplementation to help mitigate some of these side effects. If any side effects persist or worsen, it’s important to communicate this to your physician, as there may be strategies to alleviate them. This medication can suppress immune function and may lead to complications involving your blood, liver, or kidneys. Routine monitoring through blood tests, imaging, and physical evaluations may be necessary both before and during treatment to identify potential issues. Prior to initiation, inform your doctor about any pre-existing stomach, liver, or kidney issues, as well as any other medications you are currently taking, since numerous drugs can interact with this treatment. Use during pregnancy and lactation is not recommended due to potential risks to the fetus or infant. Additionally, alcohol consumption is advised against while on this medication, given the increased risk of liver injury.